EUVIMEDEUVIMED entdecken
Crossref

Dietary supplementation of probiotic Lactobacillus modulates metabolic dysfunction‐associated steatotic liver disease and intestinal barrier integrity in obesity‐induced mice

Nageena Qayyum, Mohamedelfatieh Ismael, Han Haoyue, Honghui Guo, Xin Lü iD

Journal of Food Science · 2024

DOI: 10.1111/1750-3841.17439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Science, 2024. Verfasst von Nageena Qayyum und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Engineering, Northwest Agriculture and Forestry University, Xianyang, China. Hauptthemen laut MEDLINE: Probiotics, Obesity, Diet, High-Fat, Dietary Supplements. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Shaanxi Key R&D Plan Project-Key Industrial Innovation Chain Project, Research and Development of Quality Safety Early Warning Technology and Multi-level Traceability System of Superior Agricultural and Livestock Products, Shaanxi Science and Technology Innovation Team Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The impact of Lacticaseibacillus paracasei NWAFU334 and Limosilactobacillus fermentum NWAFU0035 on the amelioration of liver function, oxidative stress reduction, and lipid metabolism modulation in mice subjected to an obesity‐inducing high‐fat diet (HFD) model was investigated. L. paracasei NWAFU334 and L. fermentum NWAFU0035 supplementations over 12 weeks have been shown to have numerous beneficial effects in mice with induced obesity. These effects comprise the restoration of liver function and the reduction of oxidative stress within the liver. Furthermore, the supplementation led to a decreased content of fat accumulation in the liver, mitigation of the expression of inflammatory cytokines in the liver and colon, and a decrease in the expression levels of tight‐junction proteins, for example, claudin‐1, PPARγ, occludin, and ZO‐1. Additionally, a notable improvement in the colonic expression proteins, including IL‐6, TNF‐α, IL‐1β, Muc‐2, Muc‐3, Zo‐1, claudin‐1, and occludin. These proposed strains considerably decreased proinflammatory cytokines and influenced the regulation of lipid metabolism in the liver. These findings indicate that the potential mechanisms, primarily the impact of L. paracasei NWAFU334 and L. fermentum NWAFU0035 on obesity‐induced liver function in mice, involve two regulated pathways: downregulation of lipogenesis and upregulation of gene expression related to fatty acid oxidation and lipolysis. In other words, these probiotic bacterial strains might be beneficial in reducing fat production and increasing fat breakdown in the liver. They may serve as effective therapeutic supplements for alleviating abnormalities induced by an HFD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsObesityDiet, High-FatDietary SupplementsLimosilactobacillus fermentumLipid MetabolismLiverAnimalsMiceMaleOxidative StressMice, Inbred C57BLCytokinesLactobacillusIntestinal MucosaLacticaseibacillus paracaseiFatty LiverTight Junction ProteinsZonula Occludens-1 ProteinColon

Stichwörter der Autor:innen

L. paracasei NWAFU334 L. fermentum NWAFU0035intestinal barrier integrityliver oxidative stressproinflammatory cytokines

Substanzen

CytokinesTight Junction ProteinsZonula Occludens-1 Protein

Autor:innen und Institutionen

  • College of Food Science and Engineering, Northwest Agriculture and Forestry University, Xianyang, China.
  • Shaanxi Engineering Research Centre of Dairy Products Quality, Safety, and Health Shaanxi, Shaanxi, China.
  • School of Public Health, Guangdong Medical University, Dongguan, China.
  • College of Food Science, South China Agricultural University, Guangzhou, China.

ORCID-Profile: Xin Lü

Förderung

  • Shaanxi Key R&D Plan Project-Key Industrial Innovation Chain Project
  • Research and Development of Quality Safety Early Warning Technology and Multi-level Traceability System of Superior Agricultural and Livestock Products
  • Shaanxi Science and Technology Innovation Team Project
  • Xianyang Key Research and Development Plan

Zitieren

APA

Qayyum, N., Ismael, M., Haoyue, H., Guo, H., & Lü, X. (2024). Dietary supplementation of probiotic Lactobacillus modulates metabolic dysfunction‐associated steatotic liver disease and intestinal barrier integrity in obesity‐induced mice. Journal of Food Science. https://doi.org/10.1111/1750-3841.17439

Vancouver

Qayyum N, Ismael M, Haoyue H, Guo H, Lü X. Dietary supplementation of probiotic Lactobacillus modulates metabolic dysfunction‐associated steatotic liver disease and intestinal barrier integrity in obesity‐induced mice. Journal of Food Science. 2024. doi:10.1111/1750-3841.17439

BibTeX
@article{Qayyum2024,
  author = {Qayyum, Nageena and Ismael, Mohamedelfatieh and Haoyue, Han and Guo, Honghui and Lü, Xin},
  title = {Dietary supplementation of probiotic Lactobacillus modulates metabolic dysfunction‐associated steatotic liver disease and intestinal barrier integrity in obesity‐induced mice},
  journal = {Journal of Food Science},
  year = {2024},
  doi = {10.1111/1750-3841.17439}
}
Kostenlos starten →